MX340487B - Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. - Google Patents

Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.

Info

Publication number
MX340487B
MX340487B MX2013004457A MX2013004457A MX340487B MX 340487 B MX340487 B MX 340487B MX 2013004457 A MX2013004457 A MX 2013004457A MX 2013004457 A MX2013004457 A MX 2013004457A MX 340487 B MX340487 B MX 340487B
Authority
MX
Mexico
Prior art keywords
diagnosing
diseases
imaging
compounds
treatment
Prior art date
Application number
MX2013004457A
Other languages
English (en)
Other versions
MX2013004457A (es
Inventor
Lehmann Lutz
Andrea Thiele
Kettschau Georg
Heinrich Tobias
Nag Sangram
Varrone Andrea
Gulyas Balazs
Halldin Christer
Original Assignee
Piramal Imaging Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Imaging Sa filed Critical Piramal Imaging Sa
Publication of MX2013004457A publication Critical patent/MX2013004457A/es
Publication of MX340487B publication Critical patent/MX340487B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/14—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups
    • C07C209/16—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Esta invención se relaciona con compuestos novedosos adecuados como precursores para la preparación de ciertos trazadores de tomografía de emisión positrónica (PET) marcados con 18F. Además, la invención se relaciona con la preparación de esas moléculas precursoras y con la preparación de trazadores de PET por marcación con 18F de esos precursores.
MX2013004457A 2010-10-22 2011-10-17 Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. MX340487B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10188559A EP2450332A1 (en) 2010-10-22 2010-10-22 Compounds for use in Imaging, diagnosing and/or treatment of diseases of the central nervous system (F-D2-Deprenyl)
PCT/EP2011/068124 WO2012052409A1 (en) 2010-10-22 2011-10-17 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system

Publications (2)

Publication Number Publication Date
MX2013004457A MX2013004457A (es) 2013-09-16
MX340487B true MX340487B (es) 2016-07-11

Family

ID=43760025

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004457A MX340487B (es) 2010-10-22 2011-10-17 Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.

Country Status (19)

Country Link
US (1) US9314540B2 (es)
EP (2) EP2450332A1 (es)
JP (1) JP5964840B2 (es)
KR (1) KR101852647B1 (es)
CN (2) CN104478735B (es)
AR (1) AR083519A1 (es)
AU (1) AU2011317664A1 (es)
BR (1) BR112013009861A2 (es)
CA (1) CA2815401C (es)
DK (1) DK2630104T3 (es)
EA (1) EA023820B1 (es)
HK (1) HK1203190A1 (es)
IL (1) IL225855A0 (es)
MX (1) MX340487B (es)
NZ (1) NZ610736A (es)
PH (1) PH12013501017A1 (es)
SG (1) SG189478A1 (es)
TW (1) TW201225979A (es)
WO (1) WO2012052409A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
US9988336B2 (en) 2014-03-18 2018-06-05 Mayo Foundation For Medical Education And Research Gaseous F-18 technologies
SI3143011T1 (sl) 2014-05-13 2021-08-31 F. Hoffmann-La Roche Ag Devterirane heterociklične spojine in njihova uporaba kot kontrastna sredstva
CN107445798B (zh) * 2016-06-01 2020-11-03 中国农业大学 一种α,α‐二氘代醇类化合物的合成方法
GB202105950D0 (en) * 2021-04-26 2021-06-09 Ge Healthcare Ltd Analytical HPLC

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL183266B1 (pl) * 1995-03-02 2002-06-28 Scherer Ltd R P Doustna kompozycja farmaceutyczna,sposób wytwarzania doustnej kompozycji farmaceutycznej oraz zastosowanie doustnej kompozycji farmaceutycznej
CN1178461C (zh) * 1998-06-09 2004-12-01 松下电器产业株式会社 图像编码装置、图像译码装置、传真装置
EP2053033A1 (en) 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
KR101619564B1 (ko) 2009-04-23 2016-05-10 바이엘 파마 악티엔게젤샤프트 Ｆ-18 표지 ｐｅｔ 추적자에 관한 신규 전구체 분자

Also Published As

Publication number Publication date
AU2011317664A1 (en) 2013-05-23
TW201225979A (en) 2012-07-01
US9314540B2 (en) 2016-04-19
WO2012052409A1 (en) 2012-04-26
HK1203190A1 (en) 2015-10-23
CN103443056A (zh) 2013-12-11
DK2630104T3 (en) 2018-07-16
PH12013501017A1 (en) 2017-08-23
CA2815401A1 (en) 2012-04-26
EP2450332A1 (en) 2012-05-09
KR101852647B1 (ko) 2018-04-26
SG189478A1 (en) 2013-05-31
CN104478735A (zh) 2015-04-01
BR112013009861A2 (pt) 2019-09-24
US20130336890A1 (en) 2013-12-19
EP2630104A1 (en) 2013-08-28
MX2013004457A (es) 2013-09-16
NZ610736A (en) 2014-11-28
EP2630104B1 (en) 2018-04-04
EA023820B1 (ru) 2016-07-29
CN104478735B (zh) 2017-05-31
JP5964840B2 (ja) 2016-08-03
EA201300479A1 (ru) 2013-10-30
KR20140023870A (ko) 2014-02-27
JP2014502257A (ja) 2014-01-30
IL225855A0 (en) 2013-07-31
CA2815401C (en) 2019-04-09
AR083519A1 (es) 2013-03-06

Similar Documents

Publication Publication Date Title
NZ590923A (en) Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
MX2013012793A (es) Aminoacidos radiomarcados para imagen de diagnostico.
PH12016500656A1 (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
WO2009052970A3 (en) Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
BR112012016376A2 (pt) compostos de pirrolo-aminopirimida substituída
JOP20110402B1 (ar) الأجسام المضادة ل cd38
SG10201810357WA (en) Ly75 as cancer therapeutic and diagnostic target
PH12015500252A1 (en) Niclosamide for the treatment of solid tumors
MX2013010012A (es) Analogos de octreotato radiomarcado como trazadores de tomografia por emision de positrones.
MX2011010295A (es) Reactivos de radiomarcado y metodos.
PH12013501017A1 (en) Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system
WO2012116196A3 (en) Substituted lactosyl compounds and use thereof for cellular imaging and therapy
AU2010332841A8 (en) Prostate specific membrane antigen inhibitors
IN2014DN10081A (es)
GB201121914D0 (en) Method for patient selection
WO2012151464A3 (en) Use of radiographic contrast agents for detecting dental caries
MX2013006202A (es) Metodo de radioconjugacion.
MX2013012795A (es) Procursores novedosos de derivados de glutamato.
WO2012040138A3 (en) Choline analogs as radiotracer
MX2013010781A (es) Compuestos para usarse en formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.
WO2013173746A3 (en) Fluorinated derivatives of 4-aminopyridine
BR112013006498A2 (pt) composto
WO2012033374A3 (ko) 1,2,3-트리아졸륨 염을 갖는 설포네이트 전구체, 그 제조방법 및 이를 사용하는 분자내 친핵성 플루오르화반응
IN2014DN06805A (es)
MX2011011191A (es) Nuevas moléculas precursoras para marcadores de pet marcados con f-18.

Legal Events

Date Code Title Description
FG Grant or registration